Granules India Limited has received the Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency (PMDA), Japan for its Jeedimetla facility, located at Jeedimetla, Quthbullapur Mandal, Medchal-Malkajgiri District, Hyderabad, Telangana. The certification has been received for accreditation categories of non-sterile Drugs, Packaging, Labelling and Storage of Drugs. Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
418.2 INR | -1.51% | -2.53% | +3.15% |
05-15 | Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024 | |
05-15 | Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.15% | 1.21B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India Limited Receives Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency